title: Length of chemotherapy and use of bevacizumab for breast cancer.
authors.affiliation: University of Pittsburgh, 300 Halket Street, Suite 4628, Pittsburgh, PA 15241, USA. Electronic address: brufskyam@upmc.edu.
authors.forename: Adam
authors.initials: A
authors.lastname: Brufsky
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D000068258:Bevacizumab; D001943:Breast Neoplasms / Q000188:drug therapy*; D000069287:Capecitabine; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000077143:Docetaxel; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000031:analogs & derivatives*; D006801:Humans; D043823:Taxoids / Q000008:administration & dosage*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D043823:Taxoids; D003841:Deoxycytidine; D000077143:Docetaxel; D000068258:Bevacizumab; D000069287:Capecitabine; D005472:Fluorouracil